Literature DB >> 12476023

Efficacy of sequential chemotherapy including methotrexate and doxorubicin in an infant with partially resected choroid plexus carcinoma.

Amedeo Fiorillo1, Giuseppe Maggi, Sossio Cirillo, Roberta Migliorati, Floriana Buffardi, Elvira Alfieri, M Simona Sabbatino, Alessandra D'Amico, M Laura DelBasso DeCaro.   

Abstract

This report refers to a 3-month-old male, with a residual choroid plexus carcinoma following partial resection, who was successfully treated with sequential chemotherapy without any postoperative radiation therapy. Along with carboplatin, we also used doxorubicin and methotrexate, hypothesizing that, given the patient's age, the blood-brain barrier should not hamper drug delivery to the tumor. According to this hypothesis, the treatment achieved complete remission of the disease, which lasts 27 months after the diagnosis. This result deserves further studies to assess the possible curative role of chemotherapy in very young patients suffering from choroid plexus carcinoma. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12476023     DOI: 10.1159/000067559

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  3 in total

1.  The role of chemotherapy and surgical removal in the treatment of Choroid Plexus carcinomas and atypical papillomas.

Authors:  Annalisa Passariello; Maria Tufano; Pietro Spennato; Lucia Quaglietta; Antonio Verrico; Roberta Migliorati; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2015-04-12       Impact factor: 1.475

2.  Histone acetylation resulting in resistance to methotrexate in choroid plexus cells.

Authors:  Preethi Prasad; Hernan Vasquez; Chandra M Das; Vidya Gopalakrishnan; Johannes E A Wolff
Journal:  J Neurooncol       Date:  2008-10-14       Impact factor: 4.130

3.  Imatinib mesylate treatment for platelet-derived growth factor receptor alfa-positive choroid plexus carcinoma.

Authors:  Chihiro Kawakami; Akiko Inoue; Kimitaka Takitani; Motomu Tsuji; Kimiko Wakai; Hiroshi Tamai
Journal:  Clin Pract       Date:  2012-05-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.